A peptide antagonist of toll-like receptor 4 attenuates pain and cartilage degradation in monoiodoacetate-induced arthritis rat model. Issue 1 (April 2020) - Kim, J.; Park, H.; Hong, J.; Song, R.; Kang, S.; Yoo, S.-J.; Kim, D.